Olema Pharmaceuticals, Inc. 4

Insider Cyrus Harmon sold a total of 25,000 shares of Olema Pharmaceuticals, Inc. (OLMA) common stock over two days at around $11.58–$11.71 per share.

On July 23 and July 24, 2026, reporting person Cyrus Harmon, an insider of Olema Pharmaceuticals, Inc., sold a total of 25,000 shares of Olema common stock in open market transactions at weighted average prices of $11.579 and $11.714 per share, respectively, for aggregate proceeds of approximately $292,000. Following these sales, Harmon held 702,770 shares directly and an additional 117,028 shares indirectly through Harmon Family Investors LLC, for total beneficial ownership of 819,798 shares. The sales were executed over price ranges disclosed in the footnotes, and the issuer has committed to provide a full breakdown of the shares sold at each price upon request. The indirect holdings reflect Harmon’s role as manager of the Harmon Family Investors LLC, through which he maintains beneficial ownership of those shares.

Filing Facts

CIK

1750284

Ticker

OLMA

Form

4

Source Type

fda

Accession

0001831410-26-000008

Alert Tier

5